Cure My Disease

Don't miss your cure!

 Log in / Sign up

New Alzheimer's pill aims to slow mental decline in major trial

NCT ID NCT06125951

Ongoing Disease control Sponsor: Actinogen Medical Source: ClinicalTrials.gov ↗

Summary

This clinical trial is testing whether a daily pill called Xanamem can help control symptoms in people with mild to moderate Alzheimer's disease dementia. The study involves 247 participants who will take either the medication or a placebo for 36 weeks, followed by an optional extension period. Researchers are measuring whether the treatment safely improves thinking skills and daily function compared to no treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • ACW Investigative Site 101

    Ivanhoe, Victoria, Australia

  • ACW Investigative Site 102

    Kogarah, New South Wales, Australia

  • ACW Investigative Site 103

    Erina, New South Wales, Australia

  • ACW Investigative Site 104

    Nedlands, Western Australia, Australia

  • ACW Investigative Site 105

    Chermside, Queensland, Australia

  • ACW Investigative Site 106

    Darlinghurst, New South Wales, Australia

  • ACW Investigative Site 107

    Macquarie Park, New South Wales, Australia

  • ACW Investigative Site 108

    Malvern, Victoria, Australia

  • ACW Investigative Site 109

    West Perth, Western Australia, Australia

  • ACW Investigative Site 110

    Woodville South, South Australia, Australia

  • ACW Investigative Site 111

    Newcastle, New South Wales, Australia

  • ACW Investigative Site 112

    Parkville, Victoria, Australia

  • ACW Investigative Site 113

    Birtinya, Queensland, Australia

  • ACW Investigative Site 114

    Bedford Park, South Australia, Australia

  • ACW Investigative Site 115

    Carlton, Victoria, Australia

  • ACW Investigative Site 203

    Delray Beach, Florida, 33445, United States

  • ACW Investigative Site 206

    Toms River, New Jersey, 08755, United States

  • ACW Investigative Site 207

    Decatur, Georgia, 30030, United States

  • ACW Investigative Site 208

    Englewood, Colorado, 80113, United States

  • ACW Investigative Site 209

    Sherman Oaks, California, 91403, United States

  • ACW Investigative Site 210

    Dayton, Ohio, 45459, United States

  • ACW Investigative Site 211

    Denver, Colorado, 80218, United States

  • ACW Investigative Site 212

    Portland, Oregon, 97225, United States

  • ACW Investigative Site 213

    Orange, California, 92866, United States

  • ACW Investigative Site 214

    Albany, New York, 12208, United States

  • ACW Investigative Site 215

    Bellevue, Washington, 98007, United States

  • ACW Investigative Site 216

    East Providence, Rhode Island, 02914, United States

  • ACW Investigative Site 217

    Independence, Ohio, 44131, United States

  • ACW Investigative Site 218

    Carlsbad, California, 92011, United States

  • ACW Investigative Site 219

    Staten Island, New York, 10314, United States

  • ACW Investigative Site 220

    Austin, Texas, 78757, United States

  • ACW Investigative site 201

    Miami, Florida, 33176, United States

  • ACW Investigative site 202

    New Port Richey, Florida, 34652, United States

  • ACW Investigative site 204

    Orlando, Florida, 32803, United States

  • ACW Investigative site 205

    The Villages, Florida, 32162, United States

Conditions

Explore the condition pages connected to this study.

ALZHEIMER DISEASE DEMENTIA MODERATE DEMENTIA, MILD